WSAAI 58th Annual Scientific Session

Program Summary 

 

Activity Information

WSAAI 2020 Annual Scientific Session
Grand Hyatt, Kauai, Hawaii
February 2-6, 2020

Target Audience

Practicing allergists and allied health care providers in the field of allergy and immunology.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Western Society of Allergy, Asthma and Immunology (WSAAI).   The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Joint Providership

 

Jointly Provided by the American College of Allergy, Asthma & Immunology and the Western Association of Allergy, Asthma & Immunology.

Commercial Support

This activity is supported by commercial interests.

Learning Objectives

  1. Recognize the different monoclonal antibody therapies for severe asthma and future agents in the drug pipeline
  2. Learn how gastroenterologists approach patients with mast cell disorders
  3. Recognize the current and potential roles of biologics to treat chronic rhinosinusitis
  4. Follow a world-expert in primary immunodeficiencies on how she approaches the diagnosis and treatment of PIDD
  5. Recognize the benefit working with gastroenterologists in co-managing inflammatory conditions like Eosinophilic Esophagitis (EoE). 
  6. Discover novel triggers for hypersensitivity skin diseases such as contact dermatitis
  7. Recognize how allergists can actively treat food allergies.

 

Disclosure Policy

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months.  The ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

All identified conflicts of interest must be resolved and the educational content fully vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that the disclosures be provided to the learners prior to the start of the activity.  Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist.

Learners must also be informed with off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality.  It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Expressed views do not necessarily reflect the opinions of the ACAAI.

Satellite Activities

Industry led lectures and exhibits will be conducted as optional learning opportunities in conjunction with this event. These optional activities are not certified for CME credit and are not planned or sanctioned by the American College of Allergy, Asthma and Immunology or WSAAI.

Planning Committee

The Board of Directors of the Western Society of Allergy, Asthma and Immunology (WSAAI) serves as the Planning Committee for the Educational Meeting. The Board includes the following physicians: Warner Carr, M.D.; Jennifer Namazy, M.D.; Matthew Bowdish, M.D.; Steven Machtinger, M.D.; Rene Anderson-Cowell, M.D.; David Elkayam, M.D.; Andrew White, M.D.; Neal Jain, M.D.

ADA Statement

in compliance with the Americans with Disabilities Act, WSAAI requests that any participant in need of accommodation send email to: karol@wsaai.org

Schedule

6:45 AM  WELCOME AND INTRODUCTION - Matt Bowdish, MD, Program Director/President Elect

7:00 AM  The Donald Stevenson, MD Lecture –  My Approach to Working Up Primary Immunodeficiency – Charlotte Cunningham-Rundles, MD, PhD

8:00 AM  Dietary Prevention of Food Allergy – Carina Venter PhD, RD

9:00 AM  Food Allergy Treatment – OIT, SLIT, EPIT – Brian P. Vickery, MD

10:00 AM  BREAK/EXHIBITS/POSTERS

10:30 AM  Advanced in Eosinophilic Esophagitis from the Gastroenterologist’s Perspective – Matthew J. Hamilton, MD

11:30 AM  Exercise-Induced Anaphylaxis - Anna Feldweg, MD

12:00 PM  EXHIBITS

12:30 PM  SESSION MODERATOR: Steve Machtinger, MD – Secretary/Treasurer

12:40 PM  The Harold S. Nelson, MD Lecture – Contact Dermatitis – Luz Fonacier, MD

1:40 PM  Asthma Heterogeneity – Prescott G. Woodruff, MD, MPH

2:40 PM  Exercise-Induced Bronchoconstriction – Jonathan Parsons, MD

3:40 PM  BREAK/EXHIBITS/POSTERS

4:10 PM  Everything You Wanted to Know About IVIg - Charlotte Cunningham-Rundles, MD, PhD

 4:40 PM  Diseases of the Inflammasome – Daniel Kastner MD, PhD

7:00 AM  WSAAI MEMBER BREAKFAST/BUSINESS MEETING

8:00 AM  EXHIBITS/BREAK/POSTERS

8:15 AM  SESSION MODERATOR: Warner Carr, MD Immediate Past President

8:30 AM  Advances in Chronic Rhinosinusitis - Anju T. Peters, MD

9:30 AM  Chronic Cough - Jonathan Parsons MD

10:30 AM  Systemic Manifestations of Contact Dermatitis - Luz Fonacier, MD

11:30 AM  Break

12:00 PM  Idiopathic Anaphylaxis – Anna Feldweg, MD

1:00 PM  Clonal and Non-Clonal Mast Cell Activation in the Gut – Matthew J. Hamilton, MD

2:00 PM-4:00PM  Workshop: A Simple Case of Cow’s Milk Allergy? - Carina Venter, PhD, RD & Brian P. Vickery, MD

11:30 AM  EXHIBITS/POSTERS

12:00 PM  SESSION MODERATOR - Matt Bowdish, MD Program Director/President Elect

12:30 PM  Spoiled for Choice II: Choosing the Right Biologic in Severe Asthma – Prescott G. Woodruff, MD, MPH

1:30 PM  Nasal Polyposis & Biologics – Ending Surgery for Polyps? – Anju T. Peters MD

2:30 PM  Advances in Innate Immunity **TENTATIVE** - Daniel Kastner, MD, PhD

3:30 PM  BREAK/EXHIBITS/POSTERS

3:50 PM  Atopic Dermatitis and Food Allergy - Brian Vickery, MD

4:50 PM  Dietary Management of Eosinophilic Esophagitis – Carina Venter, PhD, RD

5:50 PM  Adjourn

6:30 PM-8:30PM   FAREWELL RECEPTION

Faculty

The CSAAI has assembled a world-class faculty for the 2018 Annual Meeting.

Charlotte Cunningham-Rundles, MD, PhD

Session Topics:
Everything You Wanted to Know About IVIg

My Approach to Working Up Primary Immunodeficiency

 

Anna Feldweg, MD

Session Topics:
Exercise-Induced Anaphylaxis
Idiopathic Anaphylaxis

Luz Fonacier, MD

Session Topics:
Contact Dermatitis
Systemic Manifestation of Contact Dermatitis

Matthew Hamilton, MD

Session Topics:
Clonal & Non-clonal Mast Cell Activation in the Gut
Advances in EoE Diagnosis and Treatment from the Gastroenterologist’s Perspective

Daniel Kastner, MD

Session Topics:
Diseases of the Inflammasome
Advances in Innate Immune Diseases

Jonathan Parsons, MD

Session Topics:
Exercise-Induced Bronchoconstriction
Chronic Cough

Anju Peters, MD

Session Topics:
Advances in Chronic Rhinosinusitis
Nasal polyposis and Biologics - Ending Surgery for Polyps?

Carina Venter RD, PhD

Session Topics:
Dietary Prevention of Food Allergy
Dietary Management of Eosinophilic Esophagitis

Workshop:  A Simple Case of Cow’s Milk Allergy?  (facilitated with Brian Vickery, MD)

 

Brian Vickery, MD

Session Topics:
Atopic Dermatitis and Food Allergy
Food Allergy Treatment - OIT, SLIT, EPIT

Prescott Woodruff, MD

Session Topics:
Asthma Heterogeneity
Spoiled for Choice II: Choosing the right biologic in Severe Asthma